ARESTIN® Student Access Program For Students

ARESTIN® Student Access is a program sponsored by OraPharma, Inc., the makers of ARESTIN® (minocycline HCl) Microspheres, 1 mg and designed with the help of dental educators to provide students with clinical information and hands-on training in comprehensive periodontal treatment including ARESTIN® + scaling and root planing (SRP).

Once you have completed the Student Access program, we hope you will have the knowledge you will need to recognize appropriate patients, convey the risks and benefits of treatment, and administer comprehensive treatment with ARESTIN® + SRP.

Register Now

For complete access to MyArestin.com® and access to the ARESTIN® Student Access Program materials, you must register. Registration is easy, fast, and free.

What to expect from the ARESTIN® Student Access Program

The ARESTIN® Student Access Program is designed to complement your current periodontal coursework. The ARESTIN® Student Access Program is divided into 2 sections.

ARESTIN® 101 is an introduction to periodontal disease and treatment with ARESTIN® + SRP. Clinician-patient communication is also highlighted in this section.

  • Classwork focuses on disease state and clinical efficacy and safety data
  • Laboratory session focuses on proper placement of ARESTIN® and communication techniques that can be used to explain periodontal disease and treatment options

In ARESTIN® 101 you can expect to learn:

  1. The risks and benefits of comprehensive periodontal treatment including ARESTIN® + SRP
  2. Important Safety Information
  3. How and when to use ARESTIN® appropriately
  4. The importance of good patient communication

ARESTIN® 201 deals with the clinical use and application of ARESTIN® with an emphasis on patient selection and case study development.

  • Classwork focuses on appropriate patient selection and treatment planning
  • Clinical session focuses on periodontal patient case development and treatment with ARESTIN®

In ARESTIN® 201 you can expect to learn how to:

  1. Recognize appropriate patients for periodontal treatment that includes ARESTIN® + SRP
  2. Prepare a treatment plan for a periodontal patient
  3. Apply diagnostic guidelines in a clinical setting
  4. Demonstrate competency in using ARESTIN® in a clinical setting

And more…

Your instructor will also distribute:

  • Student Education Folder—this includes patient education materials to help you prepare for clinician-patient conversations
  • ARESTIN® Demonstration Pack—this includes practice cartridges for use on a typodont and are NOT FOR CLINICAL USE
  • ARESTIN® Student Trial Kit—this includes 12 ARESTIN® Cartridges to be used with patients in a clinical setting, accompanied by full prescribing information
Register Now

For complete access to MyArestin.com® and access to the ARESTIN® Student Access Program materials, you must register. Registration is easy, fast, and free.

Be Prepared

As a student, it’s important to know what you’ll be up against as a dental professional. For instance, did you know:

  • Periodontal disease affects 1 out of every 2 adult Americans1
  • 84% of patients are looking to their dental professional to give them information about periodontal disease, including risk factors, consequences, and treatment options2
REFERENCES: 1. National Institute of Dental and Craniofacial Research/Centers for Disease Control.  Oral Health, US 2002 Annual Report: Section 3.1 Percentage of adults with gingivitis. http://drc.hhs.gov/report/3_1.htm. Accessed May 3, 2011 2. Data on file. OraPharma, Inc. Horsham, PA; 2011

ARESTIN® is indicated as an adjunct to scaling and root planing (SRP) procedures for reduction of pocket depth in patients with adult periodontitis. ARESTIN® may be used as part of a periodontal maintenance program, which includes good oral hygiene and SRP.

IMPORTANT SAFETY INFORMATION

ARESTIN® should not be used in any patient who has a known sensitivity to minocycline or tetracyclines. The use of drugs of the tetracycline class during tooth development may cause permanent discoloration of the teeth, and therefore should not be used in children or in pregnant or nursing women. Hypersensitivity reactions that included, but were not limited to, anaphylaxis, angioneurotic edema, urticaria, rash, swelling of the face and pruritus have been reported with the use of ARESTIN®. In clinical trials, the most frequently reported nondental treatment-emergent adverse events were headache, infection, flu syndrome and pain.

Please see Full Prescribing Information

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Contact us with questions about your account or MyArestin.com